Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01893931 · ClinicalTrials.gov registry record · NA
Use of a Brief Phone Call After ED Discharge
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 2,003
- Enrollment target
NCT01893931: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT01893931 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 2,003 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01893931, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,003 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a phone call from a nurse within 1-3 days after discharge from the Emergency Department (ED) decreases return visits to the ED/ hospital admissions/ death (combined outcome) in patients age 65 and above. As secondary outcomes, time to follow up appointment with physician and economic impact of this intervention will be assessed. Patients 65 years of age and older will be randomized following discharge from the ED into one of two groups. Group 1(Intervention) will receive a phone call collecting information about understanding of ED discharge instructions and guiding patient through the discharge instructions, and Group 2 (Placebo) will receive a follow up phone call for a satisfaction survey. We hypothesize return visits to the ED and readmission to the hospital will decrease as a result of the nurse phone call intervention.
Primary Outcome
Measured by (1) Self-report via a phone call to the patient or care giver up to 35 days post-discharge, and (2) Utilization of existing medical records.
Interventions
- BEHAVIORAL ED Discharge & Medication Call
- BEHAVIORAL Placebo Comparator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,003 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-05 |
| Phase | NA |
What the finished NCT01893931 record still lists
NCT01893931 is an interventional study that assigns participants to a tested intervention. Its 2,003 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% higher).
The record links to 0 conditions, and to 2 interventions - of which ED Discharge & Medication Call is the first listed.
NCT01893931 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01893931 about?
NCT01893931 is a clinical study titled "Use of a Brief Phone Call After ED Discharge". The purpose of this study is to determine whether a phone call from a nurse within 1-3 days after discharge from the Emergency Department (ED) decreases return visits to the ED/ hospital admissions/ death (combined outcome) in patients age 65 and above. As secondary outcomes, time to follow up appoi...
What is the current status of trial NCT01893931?
This trial is currently completed. It is a NA study. The enrollment target is 2,003 participants. The study started on 2013-08. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01893931?
The interventions under investigation include: ED Discharge & Medication Call (BEHAVIORAL), Placebo Comparator (BEHAVIORAL).
Who is sponsoring clinical trial NCT01893931?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01893931's enrollment target sits among peer trials
2,003 52nd of 2000 higher than 1,949 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia